Clinical Trial Update: Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

This document reports on a Phase 1/2 efficacy trial of targeted, local drug delivery for Crohn's disease. The study is sponsored by Teva GTC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Teva GTC | Conditions: Crohn's Disease | Phase 1, Phase 2 | Status: COMPLETED